Literature DB >> 2592767

Reconstitution of a functional IL-2 receptor by the beta-chain cDNA. A newly acquired receptor transduces negative signal.

M Tsudo1, H Karasuyama, F Kitamura, Y Nagasaka, T Tanaka, M Miyasaka.   

Abstract

The high-affinity IL-2R results from the noncovalent association between at least two subunits; alpha (p55) and beta (p70), both of which are capable of binding IL-2 with a low and intermediate affinity, respectively. Although the alpha-chain itself has been shown to be nonfunctional, suggestions have been made that the beta-chain mediates an IL-2 signal. To directly study the role of the beta-chain in the signal transduction, we transfected with the cDNA encoding the IL-2R beta-chain a human T lymphotropic virus-I-transformed T cell line, MT-1 originally expressing low-affinity alpha-chain alone, and established a stable transformant (designated MT-beta 7) which expressed both alpha- and beta-chains simultaneously. We showed 1) MT-beta 7 manifested the high-affinity IL-2 binding, which was completely disrupted by the anti-beta chain mAb (Mik-beta 1), 2) the 125I-IL-2 crosslinking patterns of MT-beta 7 were indistinguishable from those of cells expressing the native high-affinity IL-2R, 3) MT-beta 7, but not parental MT-1, internalized the bound IL-2 and responded to IL-2 with a negative signal, i.e., inhibition of the de novo DNA synthesis. These results clearly demonstrate that the beta-chain not only participates in forming the high-affinity IL-2R with the alpha-chain but also is directly involved in the IL-2 signal transduction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592767

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Soluble IL-2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy.

Authors:  J I Duncan; C Horrocks; A D Ormerod; A V Powles; P H Whiting; L Fry; A W Thomson
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.

Authors:  I D Horak; R E Gress; P J Lucas; E M Horak; T A Waldmann; J B Bolen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  CD4 and CD8 regulate interleukin 2 responses of T cells.

Authors:  K Takahashi; M Nakata; T Tanaka; H Adachi; H Nakauchi; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Four interleukin-2 surface binding proteins detected in rat spleen cells.

Authors:  R K Chopra; M P Carroll; W S May; S K Bhatia; J B Margolick; J E Nagel; W H Adler
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

5.  Cooperative interactions between the interleukin 2 receptor alpha and beta chains alter the interleukin 2-binding affinity of the receptor subunits.

Authors:  E Roessler; A Grant; G Ju; M Tsudo; K Sugamura; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Regulation of IL-2 beta receptor expression and beta-chain mRNA by human thymocytes.

Authors:  G H Reem; X Han; A Marcelli
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

7.  Interleukin 2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in a T-cell line.

Authors:  B Turner; U Rapp; H App; M Greene; K Dobashi; J Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

8.  Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.

Authors:  S D Voss; R J Robb; G Weil-Hillman; J A Hank; K Sugamura; M Tsudo; P M Sondel
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.

Authors:  N Arima; M Kamio; K Imada; T Hori; T Hattori; M Tsudo; M Okuma; T Uchiyama
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.